𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interaction of recombinant interferons with recombinant interleukin-2: Differential effects on natural killer cell activity and interleukin-2-activated killer cells

✍ Scribed by Michael J. Brunda; Deborah Tarnowski; Viveca Davatelis

Publisher
John Wiley and Sons
Year
1986
Tongue
French
Weight
701 KB
Volume
37
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recombinant interleukin 2-activated natu
Recombinant interleukin 2-activated natural killer cells regulate IgG2a production
✍ SebastiΓ‘n Amigorena; Christian Bonnerot; Wolf Herman Fridman; Jean-Luc Teillaud πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 622 KB

Laboratoire d'lmmunologie Cellulaire et Clinique, INSERM U.255, Institut Curie, Paris Recombinant interleukin 2-activated natural killer cells regulate IgGza production\* In this report we have analyzed the effect ofrecombinant interleukin 2 (rIL 2) and rIL 2-activated natural killer (NK) cells on

Natural killer cells in children with ma
Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-Ξ± and interleukin-2 on natural killer cell function against tumor cell lines
✍ Carlos S. Alvarado; Harry W. Findley; Wing C. Chan; Robert S. Hnath; Aly Abdel-M πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 708 KB

Natural killer (NK) cells and NK cell activity were determined in three groups (newly diagnosed [n = 211, on therapy [n = 211, and off therapy [n = 181) of children with various types of malignant solid tumors and in a control group (n = 26) by means of Leu-7 and Leu-llb monoclonal antibodies and a

Adoptive immunotherapy for recurrent gli
Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2
✍ Randall E. Merchant; Angus J. Grant; Lynn H. Merchant; Harold F. Young πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 565 KB

Thirteen patients with recurrent glioblastoma were treated with adoptively transferred autologous lymphokine activated killer (LAK) cells and recombinant interleukin-2 (rIL-2). Patients' blood mononuclear cells (MNC) obtained by leukapheresis were cultured at 2.5 million MNC per ml for 3 to 5 days i